Liver Cirrhosis and Its Development

Front Cover
J.L. Boyer
Springer Science & Business Media, Mar 31, 2001 - Medical - 356 pages
Liver cirrhosis is a major clinical problem worldwide and is associated with significant morbidity and mortality from its complications, such as liver cell insufficiency with coagulopathy and hepatic encephalopathy, portal hypertension with ascites and gastrointestinal bleeding, hepatorenal syndrome, HCC development and others. This volume, the proceedings of Falk Symposium 115 held in Basel, Switzerland, October 22-24, 1999 (Part II of the Basel Liver Week 1999; XI International Congress of Liver Diseases) covers our present knowledge of the aetiologies and early stages of liver cirrhosis development. Based on this information, strategies are discussed that are aimed at the prevention, early diagnosis and therapy of chronic liver diseases, thus preventing their progression to cirrhosis and its complications, including HCC development. The main topics mentioned above are complemented by three state-of-the-art chapters on modern aspects of medicine in general and hepatology in particular as well as their perspectives beyond the year 2000: `Molecular Medicine', `New Hepatitis Viruses' and `Genetic Liver Diseases: Diagnosis and Therapy'. Introductory chapters focusing on the more basic aspects of the biology of live cells as well as on the mechanisms underlying fibrogenesis, cholestasis and inflammation will be followed by a detailed discussion of the clinically most important causes of liver cirrhosis worldwide: hepatitis viruses B, C and D; toxins (alcohol, drugs and others) as well as metabolic liver diseases (haemochromatosis, Wilson disease, alpha-1-antitrypsin deficiency, porphyria cutanea tarda and protoporphyria). This book, therefore, will interest clinically oriented basic scientists as well as those in clinical practice, givng an update on many aspects of modern hepatology and its perspectives in the next millennium.
 

Contents

Molecular mechanisms of liver regeneration and hepatocyte apoptosis
3
Mechanisms of inflammation
13
Mechanisms of hepatic fibrogenesis
30
Cellular and molecular mechanisms of cholestasis
40
Hepatitis B and D virology and diagnosis
71
Liver damage and control of HBV infection role of the cellmediated immune response
77
Natural history of hepatitis B infection
83
Chronic hepatitis B new therapies
92
The effect of ursodeoxycholic acid on fibrosis markers in alcoholic liver disease
229
Drugs and toxins drug handling
236
Drugand toxininduced liver injury diagnosis natural course and therapy
242
Liverdirected gene therapy 2000 and beyond
253
Haemochromatosis pathogenesis and diagnosis
263
Haemochromatosis natural course and therapy
272
Wilson disease pathogenesis and diagnosis
278
Wilson disease natural course and therapeutic strategies
287

Virology and diagnosis of hepatitis C
98
Hepatitis C immunopathogenesis
113
Natural history of hepatitis C virus infection risk factors for disease progression
124
Hepatitis C therapeutic challenges
148
Hepatitis C evolving therapeutic strategies
156
Pathogenesis of alcoholic liver disease
163
Alcoholic liver disease natural course mechanisms and therapeutic strategies
174
Alpha1antitrypsin deficiency pathogenesis and diagnosis
298
Alpha1antitrypsin deficiency natural course and therapeutic strategies
307
The porphyrias pathogenesis and diagnosis
316
Presentation of the Hans Popper Award
343
Index
345
Copyright

Common terms and phrases

Bibliographic information